Page 3 - ஆயோக் உறுப்பினர் ஆரோக்கியம் வ்க் பால் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

This will be followed by the clinical trial of children in the age-group of 2-6 years. The enrolment of children volunteers aged 12-18 years at the All India Institute of Medical Sciences (AIIMS) has been completed and they have been given the first dose of Covaxin. “The recruitment process for the clinical trial of Covaxin among children in the age group of 6-12 years will begin from Tuesday,” Dr Sanjay Rai, Professor at the Centre for Community Medicine at the AIIMS, told PTI. The Drugs Controller General of India (DCGI) had granted permission for conducting the phase 2/3 clinical trial of Bharat Biotech’s Covaxin among children aged two to 18 years on May 12.

Sanjay raiAayog member health vk paulIndian council of medical researchCentre for community medicineIndia institute of medical sciencesAll india instituteMedical sciencesCommunity medicineDrugs controller generalBharat biotechIndian councilMedical researchசஞ்சய் ராய்ஆயோக் உறுப்பினர் ஆரோக்கியம் வ்க் பால்இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சிமையம் க்கு சமூக மருந்து